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Abstract
BACKGROUND: Colorectal cancer is the second leading cause of cancer related death in the
US. Kentucky has one of the highest rates of the disease. Approximately 1/3 of the population
has not completed screening for colon cancer as recommended by guidelines. Patient navigation
is a strategy proposed to increase completion of screening in the primary care setting.
PURPOSE: The purpose of this quality improvement pilot project was to provide preliminary
data on the impact of a patient navigation strategy to improve colon cancer screening completion
in low risk individuals.
METHODS: Colon cancer screening completion using Colonoscopy or Cologuard testing was
compared between 30 navigated patients and 30 routine care patients in a women’s health
primary care clinic. The prevalence and prevalence odds ratios were computed to measure the
association between patient navigation and the project outcome measures. The barriers to noncompletion of screening were also assessed. The overall results were compared to findings in the
New Hampshire Colorectal Cancer Screening Program PN protocol endorsed by the CDC.
RESULTS: Patients in the PN intervention group were 5 times more likely to complete colon
cancer screening than control patients (P = .021) and 2.7 more likely to also have had a
Colonoscopy date scheduled (P = .015). In addition, 55.5% of navigated patients completed
screening after receiving mailed screening enrollment forms versus 23.8% completion whose
enrollment was on an online ordering portal alone.
CONCLUSION: Patient navigation can be used as strategy for increasing colon cancer rates in
low risk individuals. Other contributors to increases in screening included having designated
personnel for enrollment processes, offering a choice in screening test, mailed reminders for
enrollment in screening, and access to an online ordering portal.
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Introduction
Globally, colorectal cancer (CRC) is the third most common cancer in the world
(American Cancer Society, 2017). CRC is the second leading cause of cancer related death in the
United States (U.S) among men and women, with 140,788 new cases diagnosed in 2015 (U.S.
Cancer Statistics Working Group, 2014). Screening can detect colon cancer earlier when
treatment is more successful, decreasing the incidence of disease and CRC mortality (American
Cancer Society, 2019). Of those individuals considered at average-risk in 2014, only 65.7% were
reported to be up to date with screening as recommended (CDC, 2014 & CDC, 2018). Multiple
barriers to screening exist that prevent proper screening completion; these include health
disparities, healthcare system barriers, patient beliefs about screening, and access to care (Ely et
al, 2016). Patient navigation (PN) is a suggested strategy supported by the Center for Disease
Control and Prevention (CDC) that can help individuals overcome these barriers and complete
CRC screening (Rice et al, 2017 & Percac-Lima et al, 2014). The purpose of this practice inquiry
project was to assess the use of a patient navigation (PN) strategy in improving completion rates
of colorectal cancer screening.

Background
As of 2015, for every 100,000 people, 38 new cases of colon and rectum cancer were
reported and 14 of those individuals died (U.S. Cancer Statistics Working Group, 2018).
Colorectal polyps can be found during screening and removed before developing into cancer. If
cancer is detected earlier through screening it is easier to treat, decreases health care costs, and
CRC can be prevented (Rice et al, 2017). The USPSTF recommends that individuals at average
risk begin screening at age 50 and continue until 75 years of age. Lower screening rates
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contribute to increased mortality from the disease (CDC, 2012). The national goal for colon
cancer screening set by the Office of Disease Prevention and Health Promotion’s initiative,
HealthyPeople2020, is 70.5% (2019). The CDC has also set a goal of 80% completion set by the
National Colorectal Cancer Round Table group (CDC, 2016). Studies have shown that increases
in screening rates can result in decreases in CRC incidence and mortality (Zauber et al, 2015),
yet many eligible people do not complete screening (Sabatino et al, 2012). The most recent data
suggest 63.1% of females and 61.8% of males were screened in 2015 on the National Health
Interview Study (CDC, 2015). Kentucky’s incidence of CRC is 48 per 100,000 individuals, the
highest rate in the US (U.S. Cancer Statistics Working Group, 2018). In 2016, only 69.7% of the
age-eligible population in Kentucky were screened, which is lower than both the HealthyPeople
2020 target of 70.5% and National Colorectal Cancer Round Table goal of 80% (CDC, 2016).
Individuals who are considered at average risk for CRC are adult’s age 50-75 years old
with absence of increased risk factors. The USPSTF considers increased risk factors to be
individuals with a personal history of colorectal cancer or adenomatous polyps, a personal
history of irritable bowel syndrome, a strong family history of colorectal cancer or polyps, or a
known family history of a hereditary colorectal cancer syndrome such as adenomatous polyposis
(FAP) or Lynch Syndrome (American Cancer Society, 2017). Despite these national guidelines,
the CDC reports that of adults aged 50 to 75 years old, one in three are not being tested for
colorectal cancer as recommended (CDC, 2017 and Ely et al, 2016).
Multiple barriers exist to screening completion such as insurance issues, lack of public
and health care provider awareness of screening, patient beliefs, and cost (Ely et al, 2016). Other
factors such as lack of access to care, health disparities, structural barriers, client’s perceptions of
testing, rigor of bowel preparation for colonoscopies, and fear of testing/results can also be
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contributing factors to poor screening rates (Ely et al, 2016). Evidence shows that CRC screening
rates in primary care can be improved using patient reminders, provider reminders, provider
assessment and feedback, reducing structural barriers, small media, professional development
training, having IT support, and patient navigation (Degroff et al, 2018). The CDC promotes
national initiatives to increase CRC screening rates, specifically a navigation model called the
New Hampshire Colorectal Cancer Screening Program (NHCRCSP). This program effectively
increased the completion rates of screening from 69.3% to 96.2% and the quality of CRC
screening by addressing some common barriers (Rice et al, 2017). A navigation model can be
helpful in overcoming the barriers to screening to ensure not only identification of those at risks
but ensuring their completion of screening.
Screening Methods
Suggested CRC screening methods include stool-based tests (gFOBT, FIT, FIT-DNA),
direct visualization tests (Colonoscopy, CT colonography, flexible sigmoidoscopy, flexible
sigmoidoscopy with FIT) or serology tests (SEPT9 DNA) (USPSTF, 2013) (see Figure 1.)
Colonoscopy is considered the gold standard or “preferred” method by the American College of
Gastroenterology (ACG) for screening (2008). Colonoscopy is the preferred method because of
the ability to view the entire colon and remove polyps or biopsy precancerous lesions during the
test (ACS, 2019). Despite this recommendation, both the American Cancer Society (ACS)
(2019) and the ACG support the use of both the cancer prevention test (Colonoscopy) and cancer
detection test (fecal DNA), depending on which screening method will be accepted by the
patient. Many individuals find it difficult to complete Colonoscopy due to rigor of bowel prep,
transportation issues, costs, and time (ACS, 2019). The ACS and ACG state the most important
method is to complete any screening at all (ACG, 2008 & ACS, 2019).
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Figure 1. Characteristics of Colorectal Cancer Screening Tests (from American Family
Physician, 2017).
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Research shows that people are not always offered a choice of CRC tests, but that people who
are able to choose the test they prefer, they are more likely to get the test done (CDC Newsroom,
2013). A randomized control trial of competing strategies demonstrated that when patients were
given a choice of screening options between FOBT and Colonoscopy, compliance with screening
almost doubled from 38% to 69%, in Colonoscopy alone (Inadomi et al, 2012).

Cologuard

Individuals find advantages to the fecal detection test where there is no bowel prep
needed, sampling can be done at home, and there are low costs of testing (ACS, 2019). For
patients at average risk, Cologuard, a Mt-sDNA or FIT DNA test (stool DNA) is a noninvasive,
FDA approved, highly-sensitive CRC screening strategy (Exact Sciences Corporation, 2018).
This screening method is a mail-in stool sample that detects altered DNA and hemoglobin in the
stool, which can analyze and detect 11 distinct biomarkers that identify cancer and precancer.
The screening test has high sensitivity (92% in detecting CRC stage I-IV) and specificity (87%),
and is built for high compliance (68%) (Imperial et al, 2014 & Inadomi et al, 2012). A recent
study found that fecal DNA testing using Cologuard was more sensitive, 92.3% in detecting
colorectal cancer over fecal occult blood testing (FOBT), 73.8% (Imperiale et al, 2014). (See
Appendices. 1)
These tests can be administered to individuals at average risk for CRC screening but are
not indicated for surveillance in high risk individuals (Exact Sciences Corporation, 2018). A
positive Cologuard results in the need for a diagnostic colonoscopy. This type of screening
method has been designed to help address some of the patient preference issues such as lack of
screening support (Exact Sciences Corporation, 2018). It is supported by the USPSTF and
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American Cancer Society for routine CRC screening at intervals of every three years for negative
results (Exact Sciences Corporation, 2019). The use of Cologuard has shown an increase in
screening rates because it is less invasive, no bowel prep is needed and there is a shorter
turnaround time from ordering to completion than Colonoscopy (Prince et al, 2016). Prince et al
reported that there was an 88.3% intent-to-screen compliance for previously non-compliant
Medicare patients when using Cologuard (Prince et al, 2016).
Literature Review
A patient navigator is someone who provides personal guidance to patients as they move
through a health care system (American Medical Association, 2015). Currently, the role is not
regulated, and a patient navigator (PN) can be a nurse, volunteer, or someone with a professional
medical, legal, financial, or administrative experience background. The PN helps the patient or
family member with different needs involving healthcare issues such as treatment or care
options, communication with the provider, managing medical paperwork, insurance, and even
accompany the patient to appointments (Simon, S. American Cancer Society, 2018). In general, a
PN offers services to the patient and guidance for them through the healthcare system where
needed. In particular, the method which combines patient education, patient communication,
and client reminders, has been shown to improve cancer screening rates in vulnerable
populations (Louden, 2015).
A systematic review demonstrated that the use of a patient navigator can increase the
number of patients who complete colonoscopy or other methods of screening in the primary care
setting. Typically, the methods utilized a process of guiding a patient through the screening
process and providing frequent client reminders (Domingo et al, 2017). In a recent

EFFECT OF A PATIENT NAVIGATOR OF CRC SCREENING

7

comprehensive patient navigator program supported by the CDC called the New Hampshire
Colorectal Cancer Screening Program (NHCRSP), patients were 11.2 times more likely to
complete their CRC screening than those who were non-navigated (Rice et al, 2017). PN models
have also been shown to increase CRC screening rates and reduce cancer screening disparities in
vulnerable patients such as low-income and racial/ethnic minority groups (Percac-Lima et al,
2014 & Rice et al, 2017). PN services that assess barriers and tailor navigation services to them
can have positive effects on quality of care and patient satisfaction (Post e al, 2014 & Lamanna
et al, 2016). One study in an urban, university-based family medicine clinic that used a “lay
cancer screening navigator” and training program for the navigator demonstrated a viable
strategy that can to be used in that it did increase colon cancer screening rates. It attributed most
of the increase in CRC screening completion to not only the use of a navigator, but in also
offering an alternative method, FIT testing in this case, as a contributing factor to increased rates
since it decreased patient barriers (Liu et al, 2014).
Navigation models that provided education regarding the colon cancer process and
procedures of screening through telephone or written communication have been shown to
motivate and support the patient to complete screening (Domingo et al, 2017 & Kanaabi et al,
2016). Those that have been most successful are navigation services tailored to the specific
screening tests, but challenges to implementing navigation services include lack of updated
electronic medical record system or funding (Sabatino et al, 2012 & Domingo et al, 2017 & Post
et al, 2014). Gaps identified in the review of the evidence showed lack of knowledge looking at
PN interventions in individuals with private insurance (Kanaabi et al, 2016) since they have
typically been most effective in vulnerable populations (Percac-Lima et al, 2014 & Rice et al,
2017 & Domingo et al, 2017). Overall, there have been viable results supporting PN to increase
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uptake of CRC screening completion, although more data is needed to support their use with
individuals other than vulnerable populations.
Quality Improvement Initiative
Quality improvement is a systematic, formal approach to the analysis of clinical practice
and efforts to improve performance (American Association of Family Practice, 2019). It is based
on determining potential areas for improvement, collecting and analyzing data, communicating
results, and ongoing evaluation (AAFP, 2019). The American Association Family Practice
(AAFP) notes that QI practices can help improve patient outcomes and support practices in
transition to quality-based payment methods of reimbursement. Quality based payment methods
include the Quality Payment Program (QPP) and the Medicare Incentive Payment Systems
(MIPS) for Medicare reimbursement (AAFP, 2019). QI initiatives can prove pivotal for clinics to
perform to help meet these set goals for reimbursement such as colon cancer screening. Quality
improvement processes aim to collect data to understand how well the system is working and to
identify potential areas for improvement (AAFP, 2019). It is an ongoing process and evaluation
where decisions for changes in the process are made based on real time analysis (AAFP, 2019).
Health Belief Model (HBM)
Incorporating principles of the Health Belief Model into the quality improvement strategy
and patient navigation aims to facilitate better outcomes. The HBM provides a framework for
understanding health seeking behavior of individuals. It is a socio psychological model that can
help us explain health seeking behaviors by looking at one’s motivational factors for and
understanding of specific health actions (Sohler et al, 2015). The HBM assesses how one’s
perceived susceptibility, perceived severity, perceived benefit, perceived barriers, and cues to
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actions affect health behaviors and decisions (Sohler et al, 2015). Since patients’ beliefs around
screening (Ely et al, 2016) have been identified as one of the largest barriers to non-completion
of screening, it can be beneficial to guide interventions for colon cancer screening based on the
theoretical framework of the HBM. PN can specifically target an individual’s perceived beliefs
concerning screening using one-on-one interaction, communication, and patient reminders to
facilitate increased uptake of screening tests. Patients frequently perceive barriers to screening
such as fear of results, fear of testing, cost, transportation issues, lack of access to care, or
opinions that screening is not needed (Ely et al, 2016). The principles of the HBM can help guide
interactions between the patient and the navigator to meet the needs of the patient and overcome
individualized barriers for non-completion of testing.

Contributing factors as mentioned in the HBM such as self-efficacy, barriers, cues-toaction, knowledge, and stage of readiness can determine achieved CRC screening completion
(Sung et al, 2008). The PN takes these factors and communication techniques into consideration
and uses them during the patient encounters. The HBM helps guide the PN’s interactions with
each patient when discussing options of screening methods as well. In this QI project, the
navigator was able to guide decision making for screening test choice based on the patient’s
perceived ability to complete the chosen testing option. PN as an intervention guided by the
HBM model can ensure a better chance of health behavior change surrounding CRC screening in
individuals.

Purpose
The goal of this quality improvement project was to assess the effectiveness of a patient
navigation strategy on CRC screening and completion in adults identified to be at average-risk in
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a primary care women’s health clinic in an urban academic medical center. The specific aims of
the project are as follows
Aim 1: Compare colorectal cancer screening completion rates between navigated and
non-navigated patients
Aim 2: Identify barriers to non-completion of screening in those individuals who received
navigation
Aim 3: Examine demographic factors among navigated and non-navigated patients
including race, ethnicity, and type of insurance
Methods
Study Permission
The QI project study received approval under the UK IRB, entitled Evaluation of an
Interprofessional Primary Care Training and Enhancement Program Survey Cover Letter
(Approved- 1/9/2018 IRB # 42943 ID # 10456). The intention of the QI project is to replicate
and adapt the PN model strategy offered by the CDC, the NHCRCSP protocol, to a women’s
health primary care clinic by examining current practice and adjusting the navigation strategy to
fit this setting.
Setting
This QI project was completed in a women’s health primary care clinic in an urban
academic medical center. The clinic consists of five physician providers and two nurse
practitioners were primary care services are provided. The project was conducted from
September 2018 until February 2019.
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Study Population
Inclusion criteria included: 1. established female patients of the clinic age 50-75 years old
2. Patients were considered low risk and are eligible for colorectal cancer screening. Exclusion
criteria are those non-English speaking, less than 50 years old, older than 75 years old, or with
increased risk factors (personal history of colon cancer or colon polyp, previously positive
screening test, history of inflammatory bowel disease (IBS) or other inherited syndromes; or a
first degree relative with CRC.
Study Design
The study was a quasi-experimental comparison group design to assess the effectiveness
of the navigation strategy on the rate of CRC screening completion and quality. Changes in colon
cancer screening rates between patients who receive navigator services and those who received
routine care were evaluated during the 6-month intervention period. Those patients who did not
complete screening were contacted to identify barriers to completion of CRC screening during
phone communication at the completion of the project.
Research Procedures & Data Collection
The QI project reviewed charts through the electronic medical record (EMR). The
Clinical Quality Safety (CQS) Review system that is incorporated into the EMR identifies
patients who are not up-to-date with preventative services for providers. Purposeful sampling of
every other chart was reviewed for inclusion criteria from this list. Further review of the chart
was done to determine if testing was performed and not documented. Charts were reviewed until
30 patients met the inclusion criteria. The sample population was then contacted on behalf of the
clinic to discuss the need for colorectal cancer screening. An additional 30 patients from the CQS
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system list were identified as a control group receiving routine care using the same chart review
process.
In the clinic, preventative screening services for colorectal cancer are offered as
colonoscopy and Cologuard, during a patient’s annual exam or established patient visit by the
provider. Routine care consists of the screening test order being placed in the EMR for
colonoscopy and then the patient being contacted by phone at later date by endoscopy for
scheduling of testing. Endoscopy then mails a packet of instructions for the testing. If Cologuard
is ordered by the provider, the ordering form is filled out that day by the patient or by the patient
with help from the provider. The form is then mailed by the patient or mailed/faxed by the clinic
office. The Cologuard representative will then contact the patient by telephone to set up services.
The PN services were completed by the primary investigator through telephone or clinic
encounters guided by a modified protocol version of the CDC’s NHCRCSP strategy (Rice et al,
2017). The steps of the protocol used included: 1. Identify low risk patients through CQS data 2.
Contact the patient to determine if they are interested in colon cancer screening because they
have not completed the screening in the recommended time frame (colonoscopy or Cologuard
stool DNA testing) 3. If the patient is willing to move forward with screening, schedule the
appropriate test and confirm test has been scheduled, if patient prefers stool DNA testing, assist
with completion of forms and follow patient updates on Cologuard provider portal (see Appendix
4.) 4. Follow up phone call prior to colonoscopy to confirm appointment and receiving bowel
prep week of testing 5. If patient chooses stool DNA testing, call to confirm receipt of test kit or
contact from Cologuard representative. 6. If results are not in chart or on provider portal, call
patient to assess barriers to completion
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The Cologuard online provider portal (see Appendix 4.) was accessed using an office
login account in which results from all providers in the enterprise can be viewed. The site
organizes results by patient name, provider, and clinic location. The patient’s results can be
searched by name/MRN or listed by provider. The status of each patient’s order is marked as
result available, kit delivered to patient, no result/reorder recommended, cancelled-suspended for
inactivity, cancelled-order expired, and due for re-screening. Positive Cologuard results trigger
the company to contact the patient and mail positive results to the provider and patient. Lack of
integration between the online portal and the clinic’s electronic medical record currently exists.
Negative results are mailed to the patient and verified by clinic office staff using the portal.
After completion of the intervention, the charts of 30 patients who received routine care
were chart audited for CRC screening completion. Additionally, a chart audit was performed of
those patients receiving PN services for CRC screening. The charts with absences of
documentation of results in the chart and/or Cologuard provider portal were considered as noncompletion. Those whose chart review indicated non-completion and received PN services were
contacted to assess barriers to completion at end of project time period. During the project,
enrollment forms for Cologuard through an online provider ordering portal became available.
Initially, patient navigation services in the intervention group who agreed to do stool
DNA testing over the telephone were then mailed a Cologuard enrollment form and instruction
sheet (see Appendix 2. and Appendix 3.) as described by the PN during the phone encounter. The
patients were then contacted by the PN to verify if they received the packet or if the online
provider portal did not indicate the order status as being received. For patients who agreed to
Cologuard, while in the office, the PN completed paperwork during clinic visit and then mailed
the form.
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During the project, the order form for Cologuard became available online through an
online provider portal. The remainder of the patients who received navigation were then enrolled
for Cologuard through this portal during phone interaction with the PN versus the mailed packet
for enrollment. Patients who were set up for Cologuard by the PN after referral from provider
were done through the online ordering portal during the visit. Data collected during the medical
record review was stored using REDCap, a secure web-based program created to support data
capture and storage for research studies, where data is securely kept on Biomedical Informatics
servers in the secure data center run by the Institute for Pharmaceutical Outcomes and Policy.
Data Analysis
Data analysis was performed following the 6-month navigation time period. Results were
analyzed using Statistical Analysis (SAS) Software as well as Statistical Package for the Social
Sciences (SPSS) software. Descriptive analysis of the sample demographics was done using
frequencies with percentages for nominal variables. The primary outcome was CRC screening
completion rates. The proportion of those who completed a colonoscopy or Cologuard among
patients who were or were not navigated (routine care) was described using frequencies with
percentages. The differences between colonoscopy or Cologuard completion between patients
who were or were not navigated was determined using chi-square with fisher's exact tests and
prevalence odds ratio. The secondary outcome measure looked at was barriers to CRC screening.
The barriers to non-completion of colonoscopy or Cologuard were described qualitatively of
those who received patient navigator services but did not complete colonoscopy or Cologuard.
Since the Cologuard enrollment process changed throughout the practice improvement study,
those who completed Cologuard enrollment through mailed instructions and paper forms versus
online forms in the navigation group were also compared using frequencies with percentages.
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Results
Sample Characteristics
The charts of thirty patients were reviewed for the routine care group. All patients were
female. The demographics were similar between both groups and consistent with the overall
demographics of the clinic. In the routine care group, most of the patients were 50-60 years old,
56.67%, and were Caucasian, 83.3%. The majority also had HMO insurance (40%). In the
patient navigation group, thirty charts were reviewed and the demographics were similar. Forty
percent of the patients were 50-60 years old, 86.67% were Caucasian, and 46.67% had HMO
insurance (see Table 1.)
Increased Screening Rates
Overall, there was a 26.63% increase in completed screening rates in those patients who
were in the patient navigation group versus routine care. The odds ratio for navigated patients
was 5 times more likely to complete screening than the non-navigated group. Ten patients in the
routine care group completed colon cancer screening and two in the routine care group. No
patients completed Colonoscopy in the routine care or intervention group. Only two patients had
Colonoscopy scheduled during the time frame of the project and when contacted by the PN
during week of testing both had rescheduled the testing date. Six patients in the PN group and 4
in the routine care had colonoscopy scheduled with verified dates of testing available in the
EMR. There was a 36.63% increase in those who completed testing or had a scheduled date for
colonoscopy confirmed in EMR versus the routine care group. The odds ratio including both of
these scenarios was calculated for patient navigation group to be 2.7 times more likely to have
completed screening or had a scheduled colonoscopy date in the EMR compared to the control
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group. (see Table 2.) Of the 10 patients completing Cologuard, 8 had negative results and 2 had
positive tests. The patients were contacted by the provider to verify positive results and
scheduled diagnostic colonoscopy. The scheduled dates of these were past the project end time.
Of note, the time from ordering to completion of testing was looked at for Cologuard
since the data was available on the online provider portal. There were 10 patients who completed
Cologuard testing in the PN group, 5 patients completed testing in less than 1 month from
ordering date, 4 patients completed in less than 2 months from ordering data, and 1 patient
completed testing in less than 3 months from ordering. Most patients completing Cologuard
testing, 50% of the patients did so within less than 1 month from the ordering date (see Figure
2).
Cologuard Enrollment Paper Form versus Online Form
Of the 30 patients in the intervention group, there were 9 patients who received mailed
paper forms for Cologuard enrollment after agreeing to test with the PN. There were 21 patients
who were enrolled in Cologuard by the PN using the online provider ordering portal. Using the
mailed paper form, five patients completed Cologuard. Out of those individuals enrolled using
the online provider portal, five patients completed Cologuard. Overall of the groups, 55.5% of
patients completed screening from the mailed enrollment forms versus 23.8% using the online
ordering portal (see Table 3.).
Barriers to Screening
Barriers were assessed through telephone communication of the patients with noncompletion of testing or no scheduled colonoscopy date in EMR (see Table 5.). Of the 16
patients contacted by the PN, 8 of the patients were unable to be reached after 2 phone attempts.
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Of the 8 patients reached by the PN, themes for non-completion of testing were time, lack of
information, or that they did not receive the Cologuard test kit. Of the patients who were to
complete colonoscopy, two of the patients stated there was not enough time or work
commitments contributed to them being unable to complete testing. One patient rescheduled her
Colonoscopy due to fear of testing and felt she had lack of information. The other patient who
rescheduled Colonoscopy stated it was due to time and being unable to take off work.
“I have been unable to take off work because my mom has been sick and I had to take off
work to care for her, so I rescheduled my colonoscopy”
“I got really nervous about colonoscopy testing and rescheduled, I didn’t feel I had
enough information, and was unable to find transportation, I just got scared, but I will go
to the rescheduled date”
Twelve of the patients were scheduled for Cologuard and did not complete testing. The
Cologuard representative was contacted for clarification and data collected for the 12 patients
who status was “order cancelled for inactivity” on the provider online ordering portal at the end
of the project time. Order cancelled for inactivity means the patient has the kit and has had it for
at least 60 days but has not submitted it. This status means the company is waiting for the patient
to complete it. Three compliance phone calls and 1 letter are sent to the patient prior to reaching
this order status. If they have reached this status, they are no longer contacted by the Cologuard
representatives, although their order would still be active for 365 days from the order date
(Brooke Sorgi, Exact Sciences Corporation Cologuard National Account Manager, 2019).
These 12 patients were then contacted by the PN to assess barriers. 6 of these patients
were unable to be reached by the PN. Of those patients able to be reached, 2 confirmed with the
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PN they had not had time to complete testing kit although received it, 2 said they never received
the kit, 1 was unable to give a reason for non-completion, and 1 attributed it to being unable to
provide an adequate stool sample.
“I have had very liquid stool lately, but when I can give a good sample, I will contact Cologuard
and send it”
Discussion
The findings of the QI project highlight the benefit of a PN strategy for increasing colon
cancer screening in this population. Using an adapted PN protocol from the New Hampshire
Colorectal Cancer Screening Program (NHCRCSP), patients were 5 times more likely to
complete colon cancer screening. They were also 2.7 times more likely to at least have had their
colonoscopy date scheduled. In addition, it demonstrated that among patients completing
Cologuard, they were more likely to complete screening if they were mailed reminders with
instructions for enrollment than by using an online ordering portal alone. Although outcomes in
this QI were less than those found in the NHCRSCP study (odds ratio of 11.2 versus 5) they
similar trends.
The NHCRCSP is a patient navigation model for public health that was highly effective
at increasing screening completion and quality of colonoscopy for low income, underinsured
groups. The navigated patients were 11.2 times more likely to complete their colonoscopy than
non-navigated patients (Rice et al, 2017). The CDC has a protocol manual to help others
replicate the model. The protocol used in this QI project was modeled after the NHCRCSP but
modified to fit the different clinical setting. This QI initiative showed that navigated patients

EFFECT OF A PATIENT NAVIGATOR OF CRC SCREENING

19

were 5 times more likely to complete colon cancer screening than the non-navigated patients in
comparison to 11.2 times in the NHCRCSP model.
Some of the main differences in this model were the setting and demographics of the
groups receiving patient navigation. Their protocol looked at 131 patients receiving navigation
versus 75 who were non-navigated. They evaluated average and increased risk groups while this
QI project only looked at low risk individuals. Another difference was that their model goal was
to complete only colonoscopies over a 12-month timeframe while this QI project offered both
Colonoscopy and Cologuard as options for screening in a 6-month timeframe.
The NHCRSCP consisted of 6-steps; “topics” were described in detail to guide the
interactions between the patient and patient navigators with extensive partnerships in the care
system. They had strong collaborations with the endoscopy center and more than one patient
navigator in which the QI project in this setting lacked both (Rice et al, 2017). The NHCRSCP
suggested that a limitation of the study was that it did not offer alternative screening methods
such as fecal occult blood test or fecal immunochemical tests and adaptation of this program
including alternative testing options in the future would be useful. The results of this QI showed
that individuals offered an alternative screening test (Cologuard) during PN were more likely to
choose this option in that 10 navigated patients completed Cologuard and 0 had completed
colonoscopies at the end of the project.
There are several factors that may have contributed to the effectiveness of this model.
One was having a single patient navigator. The navigated patients received phone calls from a
single navigator who actively tried to establish a relationship with the patient. The navigator was
also an RN who was an expert in the online ordering portal offered by Cologuard. The short time
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frame of the study also contributed to the frequency and timing of calls delivered. Having one
consistent navigator and screening enrollment process could have influenced the patient’s
willingness to complete screening. Another factor was that the patient navigator was able to offer
two forms of screening tests. During phone encounters with the patients many declined
Colonoscopy but were willing to complete Cologuard. Giving patients an option seemed to
increase their likelihood to completing the test. In this setting, the providers were also able to
order testing for Colonoscopy in the electronic medical record (EMR) but had no ability to order
Cologuard or verify results in the EMR. This factor may have contributed to the effectiveness of
the processes used for Cologuard enrollment by the PN versus if the clinic did have Cologuard
ordering embedded in the EMR. Since the overall results in this QI were consistent with those of
the NHCRSCP although not as strong, the ability to replicate more aspects of this model could
increase the effect of a PN strategy in this setting.
Given the significant finding of the use of mailed enrollment instructions for Cologuard,
in which 55.5% of patients completed testing versus 23.8% in those enrolled on the online portal,
a recommendation for the future could include both mailed reminders for screening enrollment
processes and order placement in the online portal. Patient navigation in this study also showed
that having one designated personnel to organize enrollment could have contributed to increased
screening completion. If one person is not designated, then having a standardized enrollment
system for all providers can also be key. An important area for future research could include
using a standardized screening enrollment process or a proposed mailed screening form (see
Appendix 5) for patients requiring screening. An algorithm of the protocol that can be used for
patient navigation services in the future was also developed (see Appendix 6).
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Limitations
Limitations of the project were small sample size and lack of demographic variation. The
majority of the patients were Caucasian (86.67% in intervention group and 83.3% in control
group) with HMO insurance (46.6% in intervention group and 23.3% in control group). This
prevents results from this study to be generalized to other settings such as the success of the
NHCRSCP in vulnerable populations. Another limitation was the long time period of scheduling
colonoscopy. Time to scheduling of colonoscopy from ordering the test was longer than the time
frame of the study, 6-months. For this reason, no colonoscopy results were available, although
scheduling dates were assigned. Patients who scheduled their colonoscopy still did not complete
it. Since the scheduling dates were past the time period of the project, the use of patient
navigation for completing colonoscopy as the chosen screening method was unable to be
analyzed. In addition, lack of consistency in provider documentation and variations of charting
for CRC screening test completion made it difficult to determine who needed screening in the
control group. Also, results from outside facilities were not available and therefore could have
hindered results of those considered non-completion in this group.
Future Recommendations
Clinical Practice
The findings of this QI confirm the importance of developing CRC screening
improvement interventions in the future since rates of completion did improve. Improvements in
screening processes are necessary for healthcare facilities moving to quality-based payment for
insurance reimbursement. It is now more important than ever since new guidelines by the
American Cancer Society (ACS) are recommending average risk screening begin at age 45
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contrary to the current age of 50. The ACS’s data shows that new cases of colorectal cancer are
occurring at increasing rates among younger adults (ACS, 2018). This change in
recommendation will increase the population requiring screening. Within these guidelines multitarget stool DNA testing every 3 years is an acceptable form of screening by the ACS. Since the
number of individuals requiring screening will increase significantly, alternative forms of
screening, non-invasive methods, and timely screening methods such as stool DNA testing can
truly make an impact on increasing the number of individuals who are screened. Evidence from
this QI project supports this in that there was 36.6% increase in screening completion and all the
patients completing testing performed Cologuard.
This practice improvement project suggests that giving patients the choice, reducing time
from ordering to scheduling, clinics providing patient support for testing enrollment form
completion, and using an organized system connected to the EMR can help increase screening
rates. These findings are consistent with the American Cancer Society’s emphasis that individual
preference, choice in testing options, and strong follow-up are needed to have positive results
(2018). Patient navigation is a method that can help combine these factors in the future. Patient
navigation is a strategy that may prove useful in the future for reaching individuals requiring
screening.
Summary
Colorectal Cancer in the United States is among the most widespread cancers with
significant disease burden if not diagnosed early. Prevention and early recognition of the disease
are key to making an impact on reducing mortality and morbidity from the disease. Primary care
providers are vital in recommending screening to patients for prevention, although they are not
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the only factor that can help increase disease screening rates. The importance of increasing
screening rates now more than ever is due to changes in the ACS guidelines proposing screening
now be done at a younger adult age of 45 instead of 50 (ACS, 2019). Thus, the population at risk
will increase drastically.
Suggestions for improving CRC screening rates are giving patients at average risk a
choice between screening methods, utilization of an online ordering portal, mailed screening
enrollment reminders, reducing time between ordering and scheduling of screening tests, and a
platform for ordering alternative screening methods to Colonoscopy that are embedded into
EMR’s. Having a systematic approach that involves the electronic medical record across the
entire healthcare system such as patient navigation can help improve rates. Using quality
improvement methods can make a difference in clinical practice for standardizing CRC
screening processes for increasing screening rates.
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Appendix 1.
Cologuard at Home Testing Instructions, Mailed to Patient with Kit by Exact Sciences
Corporation
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Mailed Screening Enrollment Instructions
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Cologuard Order Requisition Paper Form
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Appendix 4.
Exact Sciences Cologuard Online Provider Portal Screenshot
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Appendix 5.
Suggested Screening Enrollment Instructions Form for Mailing
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Patient Navigation Proposed Protocol
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Tables and Figures
Table 1.
Sample Characteristics
Demographic

Navigation
Group N=30

Percentage Non-navigation
of group
Group N=30

Percentage
of group

50-60 years

13

43.3%

17

56.67%

60-70 years
70-75 years

12
5

40%
5%

10
3

33.3%
10%

Caucasian
African
American
Asian

26
2

86.6%
6.67%

25
3

83.3%
10%

2

6.67%

2

6.67%

Medicare

5

16.67%

9

30%

Medicaid
HMO
PPO

7
14
4

23.3%
46.67%
13.3%

2
12
7

6.67%
40%
23.3%

Age

Ethnicity

Insurance
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Table 2.
Outcome Measures
Outcome
Measure

Navigation
Group N=30

Percentage
of group

NonNavigation
Group N=30

Percentage
of group

Cologuard

10

33.3%

2

6.67%

Colonoscopy

0

Total

10

33.3%

2

6.67%

Cologuard
completion

10

33.3%

2

6.67%

Colonoscopy
completion

0

Colonoscopy
scheduled date
in EMR

6

20%

4

13.3%

Total

16

53.3%

6

16.67%

Odds
Ratio

P-value
(chisquare)

5

(P=.021)

2.7

(P=.015)

Screening
Completion
0

Screening
completion +
Colonoscopy date
scheduled in EMR

0

Table 3.
Difference in Mailed versus Online Cologuard Enrollment Table

Mailed Screening Enrollment
Instructions (N=9)

Completion of Screening

Non-completion of Screening

No. (%)

No. (%)

5 (55.5)

4 (44.4%)
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Enrollment Form in Online
Ordering Portal (N=21)

5 (23.8)

16 (76.2)

Figure 2.
Time to Cologuard Completion Graph

Time to Cologuard Completion
Number of Patients (N=10)

<3 months

<2 months

<1 month

0

1

2

3

4

5

6
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Table 4.
Expressed Barriers to Non-completion of Colon Cancer Screening Among Navigated Patients
Barriers to
Noncompletion
Themes

Lack of
transportation

Noncompletions
Cologuard

Noncompletions
Colonoscopy

Lack of
time/out
of town

Fear of
testing

2

2

1

Did not
receive
kit

Unable to
provide
adequate
stool
sample

Lack of
information
around
testing

Unable to
reach
patient

1

1

1

6

1

***Total N=16, number of times theme was identified upon barrier assessment

1

EFFECT OF A PATIENT NAVIGATOR OF CRC SCREENING

Figure 2.
Time to Cologuard Completion Graph
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